{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:05:38Z","timestamp":1788570338365,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013278","name":"JPND","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.neurobiolaging.2013.11.010","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T04:22:06Z","timestamp":1384575726000},"page":"1177-1188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases"],"prefix":"10.1016","volume":"35","author":[{"given":"Matthias","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"L\u00fcllmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wohlhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteleimon","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","article-title":"Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease","volume":"353","author":"Alperovitch","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12031-008-9053-y","article-title":"Oligodendroglial cells and neurotrophins: a polyphonic cantata in major and minor","volume":"35","author":"Althaus","year":"2008","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib3","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/brain\/awg205","article-title":"Regional heterogeneity of cellular prion protein isoforms in the mouse brain","volume":"126","author":"Beringue","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0736-5748(97)00042-7","article-title":"Effects of oxidative stress on prion protein expression in PC12 cells","volume":"15","author":"Brown","year":"1997","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib5","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/brain\/awl224","article-title":"Classification of sporadic Creutzfeldt-Jakob disease revisited","volume":"129","author":"Cali","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)64572-5","article-title":"Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain","volume":"157","author":"Capellari","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/1522-2683(200202)23:2<339::AID-ELPS339>3.0.CO;2-Y","article-title":"Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system","volume":"23","author":"Castagna","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib8","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","article-title":"Truncated forms of the human prion protein in normal brain and prion diseases","volume":"270","author":"Chen","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1044-7431(02)00014-3","article-title":"Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival","volume":"22","author":"Chen","year":"2003","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/labinvest.2009.30","article-title":"Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease","volume":"89","author":"Choi","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib11","doi-asserted-by":"crossref","first-page":"40624","DOI":"10.1074\/jbc.M506069200","article-title":"The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity","volume":"280","author":"Ciss\u00e9","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib12","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib13","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1073\/pnas.0702662104","article-title":"Formation of native prions from minimal components in\u00a0vitro","volume":"104","author":"Deleault","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0272-2712(02)00065-3","article-title":"Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia","volume":"23","author":"Gambetti","year":"2003","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: classification and characterization","volume":"66","author":"Gambetti","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000334499","article-title":"Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis","volume":"9","author":"Gawinecka","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib17","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1523\/JNEUROSCI.2294-09.2009","article-title":"Phosphorylation of prion protein at serine 43 induces prion protein conformational change","volume":"29","author":"Giannopoulos","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/brain\/awl013","article-title":"Distinct glycoforms ratios of protease resistant prion protein associated with PRNP point mutations","volume":"129","author":"Hill","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199104183241604","article-title":"Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease","volume":"324","author":"Hsiao","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0002-9440(10)65744-6","article-title":"Endogenous proteolytic cleavage of normal and disease- associated isoforms of the human prion protein in neural and non-neural tissues","volume":"153","author":"Jim\u00e9nez-Huete","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib21","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1742-4658.2007.05691.x","article-title":"Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse","volume":"274","author":"Kuczius","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1471-4159.2005.03104.x","article-title":"Prion protein glycosylation","volume":"93","author":"Lawson","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biolcel.2003.11.007","article-title":"Alpha- and beta cleavages of the amino-terminus of the cellular prion protein","volume":"96","author":"Mang\u00e9","year":"2004","journal-title":"Biol. Cell"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0197-0186(02)00054-2","article-title":"The biology of the cellular prion protein","volume":"41","author":"Martins","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","article-title":"Familial and sporadic fatal insomnia","volume":"2","author":"Montagna","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-2009-1110","article-title":"Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders","volume":"17","author":"Meyne","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","article-title":"Signal transduction through prion protein","volume":"289","author":"Mouillet-Richard","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1046\/j.1471-4159.2002.00909.x","article-title":"Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms","volume":"81","author":"Pan","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1006\/bbrc.1996.0936","article-title":"PrP27-30 is a normal soluble prion protein fragment released by human platelets","volume":"223","author":"Perini","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.200304140","article-title":"Trafficking of prion proteins through a caveolae-mediated endosomal pathway","volume":"162","author":"Peters","year":"2003","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bbrc.2008.01.172","article-title":"Normal cellular prion protein with a methionine at position 129 has a more exposed helix 1 and is more prone to aggregate","volume":"368","author":"Pham","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/glycob\/1.1.101","article-title":"Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites","volume":"1","author":"Rogers","year":"1990","journal-title":"Glycobiology"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib34","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1073\/pnas.96.23.13044","article-title":"Glycosylation differences between the normal and pathogenic prion protein isoforms","volume":"96","author":"Rudd","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jnr.22235","article-title":"Mutual effects of caveolin and nerve growth factor signaling in pig oligodendrocytes","volume":"88","author":"Schmitz","year":"2010","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib36","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/j.1460-9568.2010.07224.x","article-title":"Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease","volume":"31","author":"Schmitz","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10571-011-9694-1","article-title":"Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades","volume":"31","author":"Schmitz","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-130566","article-title":"Impact of the cellular prion protein on amyloid-beta and 3PO-Tau processing","volume":"38","author":"Schmitz","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib39","doi-asserted-by":"crossref","first-page":"e5796","DOI":"10.1371\/journal.pone.0005796","article-title":"Prion protein expression and processing in human mononuclear cells: the impact of the codon 129 prion gene polymorphism","volume":"4","author":"Segarra","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1074\/jbc.M609663200","article-title":"The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53- dependant staurosporine-induced caspase-3 activation","volume":"282","author":"Sunyach","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib41","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0006-291X(05)80038-5","article-title":"A\u00a0soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies","volume":"184","author":"Tagliavini","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid \u00df-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib43","doi-asserted-by":"crossref","first-page":"e1000029","DOI":"10.1371\/journal.ppat.1000029","article-title":"Beyond PrPres type 1\/type 2 dichotomy in Creutzfeldt-Jakob disease","volume":"4","author":"Uro-Coste","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mcn.2008.10.012","article-title":"Alpha- cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts","volume":"40","author":"Walmsley","year":"2009","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib45","doi-asserted-by":"crossref","first-page":"35914","DOI":"10.1074\/jbc.M507327200","article-title":"Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress","volume":"280","author":"Watt","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib46","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1042\/BST0331123","article-title":"Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress","volume":"33","author":"Watt","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2004.09.030","article-title":"Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity","volume":"372","author":"Weise","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","article-title":"Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activiation, and exacerbation of ischemic brain injury","volume":"37","author":"Weise","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib49","first-page":"361","article-title":"Humans transmissible spongiform encephalopathies","volume":"47","author":"WHO","year":"1998","journal-title":"Wkly Epidemiol Rec."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s004399900124","article-title":"Molecular genetics of human prion disease in Germany","volume":"105","author":"Windl","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib51","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1073\/pnas.95.15.8812","article-title":"Prion protein expression in different species: analysis with a panel of new mAbs","volume":"95","author":"Zanusso","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1","article-title":"Two-dimensional mapping of three phenotype-associated isoforms of the cellular prion protein in sporadic Creutzfeldt-Jakob disease","volume":"23","author":"Zanusso","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib53","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(96)08077-4","article-title":"Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid","volume":"348","author":"Zerr","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib56","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.11.010_bib57","doi-asserted-by":"crossref","first-page":"40429","DOI":"10.1074\/jbc.M308550200","article-title":"Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt- Jakob disease","volume":"278","author":"Zou","year":"2003","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013005782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013005782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:21:50Z","timestamp":1759317710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013005782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0197458013005782"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}